<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>D.C. Law 22-207. Access to Treatment for Anaphylaxis Act of 2018. | D.C. Law Library</title>
    <link rel="shortcut icon" href="/us/dc/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/dc/council/laws/22-207/index.full.html"/>
    <meta itemprop="toc-json" content="/us/dc/council/laws/22-207/index.json"/>
    <meta itemprop="doc-type" content="document"/>
    <meta itemprop="ref-doc" content="D.C. Law 22-207"/>
    <!--OpenGraph-->
    <meta property="og:url" content="https://code.dccouncil.us/us/dc/council/laws/22-207"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="D.C. Law 22-207. Access to Treatment for Anaphylaxis Act of 2018. | D.C. Law Library"/>
    <meta property="og:image" content="https://code.dccouncil.us/us/dc/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="msapplication-config" content="/browserconfig.xml"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#000000"/>
    <meta name="apple-mobile-web-app-title" content="D.C. Law Library"/>
    <meta name="theme-color" content="#000000"/>
    <meta name="msapplication-navbutton-color" content="#000000"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/dc/_document/v2/images/favicons/safari-pinned-tab.svg" color="#000000"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/dc/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/dc/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/dc/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/dc/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/droid-serif/droid-serif.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/open-sans/open-sans.css" type="text/css" rel="stylesheet"/>
    <!--Document CSS-->
    <link href="/us/dc/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print"/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js"> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/dc/council/laws/22-207/index.full.html" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__us-dc">
      <header id="section__header" class="ns__document__us-dc">
        <div id="section__header__inner" class="ns__document__us-dc">
          <div id="area__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal-outline.png" srcset="/us/dc/_document/v2/images/logo/dc-seal-outline.png 1x, /us/dc/_document/v2/images/logo/dc-seal-outline@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__us-dc">
            <img src="/us/dc/_document/v2/images/logo/dccouncil_typemark.svg" srcset="" alt="D.C. Law Library"/>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__us-dc">
        <div id="section__content__inner" class="ns__document__us-dc">
          <section id="area__breadcrumbs" class="ns__document__us-dc" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library|D.C. Code" aria-hidden="true" data-search-heading="D.C. Code" data-search-default="true" class="hidden"/>
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="D.C. Law Library">D.C. Law Library</a>
                </li>
                <li data-search-path="library|dclaws" data-search-heading="D.C. Laws" class="no-indent">
                  <a href="/dclaws" title="D.C. Laws Codified in the D.C. Code">D.C. Laws Codified in the D.C. Code</a>
                </li>
                <li data-search-path="library|dclaws|22" data-search-heading="" class="no-indent">
                  <a href="/dclaws/22" title="Council Period 22 (2017-2018)">Council Period 22 (2017-2018)</a>
                </li>
                <li data-search-path="library|dclaws|22|permanent" data-search-heading="" class="no-indent">
                  <a href="/dclaws/22/permanent" title="Permanent Laws">Permanent Laws</a>
                </li>
                <li data-search-path="library|dclaws|22|permanent|D.C. Law 22-207" data-search-heading="" class="li__book-open">
                  <span title="D.C. Law 22-207. Access to Treatment for Anaphylaxis Act of 2018.">D.C. Law 22-207. Access to Treatment for Anaphylaxis Act of 2018.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__us-dc">
            <article class="content" role="document">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/dc/council/laws/22-207">D.C. Law 22-207. Access to Treatment for Anaphylaxis Act of 2018.</h1>
                <p class="text--center">AN ACT</p>
                <p class="text--italic">To allow health care professionals to prescribe and pharmacists to dispense and distribute epinephrine auto-injectors to authorized entities, to authorize employees or agents of an authorized entity who has completed a training program to provide or administer an epinephrine auto-injector, to require an employee or agent of an authorized entity to undergo training before providing or administering an epinephrine auto-injector, to authorize an authorized entity to store epinephrine auto-injectors, and to provide immunity from civil and criminal liability to certain persons and entities.</p>
                <p>BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Access to Treatment for Anaphylaxis Act of 2018".</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/titles/7/chapters/23D/subchapters/II">subchapter II of Chapter 23D of Title 7</a></span>
                  </p>
                </aside>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.01">§ 7-2381.01</a></span>
                  </p>
                </aside>
                <p id="&#xA7;2"><span class="level-num">Sec. 2. </span>Definitions.</p>
                <p>For the purposes of <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite>, the term:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(1)">(1)</span> "Administer" means the direct application of an epinephrine auto-injection to a human body.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(2)">(2)</span> "Authorized entity" means any entity or organization other than a public school, including recreational camps, colleges, universities, day care facilities, youth sports leagues, restaurants, places of employment, and sports arenas.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(3)">(3)</span> "Department" means the Department of Health.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(4)">(4)</span> "Epinephrine auto-injector" means a disposable drug delivery system with a spring-activated needle that is designed for the emergency administration of epinephrine to a person suffering an episode of anaphylaxis.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(5)">(5)</span> "Health care professional" means a physician, physician assistant, or advanced practice registered nurse licensed under <code-cite doc="D.C. Code" path="3|12">the District of Columbia Health Occupations Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1201.01 <em>et seq</em>.)</code-cite>.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;2(6)">(6)</span> "Standing order" means a prescriptive order written by a health care professional that is not specific to and does not identify a particular patient.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.02">§ 7-2381.02</a></span>
                  </p>
                </aside>
                <p id="&#xA7;3"><span class="level-num">Sec. 3. </span>Epinephrine prescriptions.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;3(a)">(a)</span> A health care professional acting in good faith may directly or by standing order prescribe an epinephrine auto-injector to an authorized entity that has an employee or agent who has completed the training program described in <code-cite doc="D.C. Code" path="&#xA7;7-2381.04">section 5</code-cite>.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;3(b)">(b)</span> A pharmacist, in accordance with a health care professional's prescription or standing order, may dispense and distribute an epinephrine auto-injector to an authorized entity to whom an epinephrine auto-injector has been prescribed.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.03">§ 7-2381.03</a></span>
                  </p>
                </aside>
                <p id="&#xA7;4"><span class="level-num">Sec. 4. </span>Authorized use.</p>
                <p>An employee or agent of an authorized entity who has completed the training program described in <code-cite doc="D.C. Code" path="&#xA7;7-2381.04">section 5</code-cite> may use an epinephrine auto-injector prescribed pursuant to <code-cite doc="D.C. Code" path="&#xA7;7-2381.02">section 3</code-cite> to:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;4(1)">(1)</span> Provide an epinephrine auto-injector to any individual who the employee or agent believes in good faith is experiencing anaphylaxis, for immediate administration;</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;4(2)">(2)</span> Provide an epinephrine auto-injector to the parent, guardian, or caregiver of an individual who the employee or agent believes in good faith is experiencing anaphylaxis, for immediate administration; or</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;4(3)">(3)</span> Administer an epinephrine auto-injector to any individual who the employee or agent believes in good faith is experiencing anaphylaxis.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.04">§ 7-2381.04</a></span>
                  </p>
                </aside>
                <p id="&#xA7;5"><span class="level-num">Sec. 5. </span>Training required.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;5(a)">(a)</span> An employee or agent of an authorized entity may not provide or administer an epinephrine auto-injector under <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite> unless he or she completes an anaphylaxis training program. The training program shall be conducted by:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;5(a)(1)">(1)</span> A nationally recognized organization experienced in training laypersons in emergency health treatment; or</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;5(a)(2)">(2)</span> An entity or individual approved by the Department.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;5(b)">(b)</span> The training program may be conducted online or in person and shall include instruction on:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;5(b)(1)">(1)</span> The recognition of signs and symptoms of severe allergic reactions, including anaphylaxis;</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;5(b)(2)">(2)</span> Standards and procedures for the storage and administration of an epinephrine auto-injector; and</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;5(b)(3)">(3)</span> Post-administration emergency medical follow-up procedures.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;5(c)">(c)</span> An organization, individual, or entity that conducts the training program shall issue a certificate, on a form developed by the Department, to each person who successfully completes the training program.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.05">§ 7-2381.05</a></span>
                  </p>
                </aside>
                <p id="&#xA7;6"><span class="level-num">Sec. 6. </span>Storing and maintaining epinephrine.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;6(a)">(a)</span> An authorized entity may acquire and maintain epinephrine auto-injectors obtained in accordance with <code-cite doc="D.C. Code" path="&#xA7;7-2381.02">section 3</code-cite>. Once acquired, the epinephrine auto-injectors shall be maintained:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;6(a)(1)">(1)</span> In a location readily accessible in an emergency situation;</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;6(a)(2)">(2)</span> In accordance with the manufacturer's instructions for storage; and</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;6(a)(3)">(3)</span> In accordance with any additional requirements that may be established by the Department.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;6(b)">(b)</span> An authorized entity shall designate employees or agents who have completed the training described in <code-cite doc="D.C. Code" path="&#xA7;7-2381.04">section 5</code-cite> to be responsible for the storage and maintenance of epinephrine auto-injectors acquired by the authorized entity.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.06">§ 7-2381.06</a></span>
                  </p>
                </aside>
                <p id="&#xA7;7"><span class="level-num">Sec. 7. </span>Limitations on liability.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;7(a)">(a)</span> The following shall be immune from civil or criminal liability for the performance of actions authorized by <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite>; provided, that no immunity shall extend to gross negligence, recklessness, or intentional misconduct:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;7(a)(1)">(1)</span> An authorized entity and its employees or agents; and</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;7(a)(2)">(2)</span> A third party that facilitates the availability of epinephrine auto-injectors to an authorized entity.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;7(b)">(b)</span> The following shall be immune from civil or criminal liability for the performance of actions authorized by <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite>; provided, that no immunity shall extend to gross negligence, recklessness, intentional misconduct, or a willful or wanton disregard for the health or safety of others:</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;7(b)(1)">(1)</span> A health care professional that prescribes epinephrine auto-injectors to an authorized entity;</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;7(b)(2)">(2)</span> A pharmacist that dispenses or distributes epinephrine auto-injectors to an authorized entity; and</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;7(b)(3)">(3)</span> An organization, individual, or entity that conducts the training described in <code-cite doc="D.C. Code" path="&#xA7;7-2381.04">section 5</code-cite>.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.07">§ 7-2381.07</a></span>
                  </p>
                </aside>
                <p id="&#xA7;8"><span class="level-num">Sec. 8. </span>Incident reports.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;8(a)">(a)</span> An authorized entity that acquires and provides or administers epinephrine auto-injectors shall submit to the Department, on a form developed by the Department, a report of each incident on the authorized entity's premises that involves the provision or administration of an epinephrine auto-injector pursuant to <code-cite doc="D.C. Code" path="&#xA7;7-2381.03">section 4</code-cite>.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;8(b)">(b)</span> By January 1, 2020, and annually thereafter, the Department shall publish a report summarizing and analyzing the reports submitted pursuant to subsection (a) of this section during the previous fiscal year.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.08">§ 7-2381.08</a></span>
                  </p>
                </aside>
                <p id="&#xA7;9"><span class="level-num">Sec. 9. </span>Rules.</p>
                <p>The Mayor, pursuant to <code-cite doc="D.C. Code" path="2|5|I">Title I of the District of Columbia Administrative Procedure Act, approved October 21, 1968 (82 Stat. 1204; D.C. Official Code § 2-501 <em>et seq</em>.)</code-cite>, shall issue rules to implement the provisions of <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite>.</p>
                <aside class="marginalia" role="note">
                  <p>
                    <span class="text--bold">New <a class="no-wrap" href="/us/dc/council/code/sections/7-2381.09">§ 7-2381.09</a></span>
                  </p>
                </aside>
                <p id="&#xA7;10"><span class="level-num">Sec. 10. </span>Applicability.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;10(a)">(a)</span> <code-cite doc="D.C. Code" path="7|23D|II">This act </code-cite> shall apply upon the date of inclusion of its fiscal effect in an approved budget and financial plan.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;10(b)">(b)</span> The Chief Financial Officer shall certify the date of the inclusion of the fiscal effect in an approved budget and financial plan and provide notice to the Budget Director of the Council of the certification.</p>
                <p class="text-indent-1"><span class="level-num" id="&#xA7;10(c)">(c)</span><span class="level-num" id="&#xA7;10(c)(1)">(1)</span> The Budget Director shall cause the notice of the certification to be published in the District of Columbia Register.</p>
                <p class="text-indent-2"><span class="level-num" id="&#xA7;10(c)(2)">(2)</span> The date of publication of the notice of the certification shall not affect the applicability of <code-cite doc="D.C. Code" path="7|23D|II">this act</code-cite>.</p>
                <p id="&#xA7;11"><span class="level-num">Sec. 11. </span>Fiscal impact statement.</p>
                <p>The Council adopts the fiscal impact statement in the committee report as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</p>
                <p id="&#xA7;12"><span class="level-num">Sec. 12. </span>Effective date.</p>
                <p>This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.</p>
              </div>
            </article>
          </main>
          <section id="area__document_meta" class="ui ns__document__us-dc">
            <h2 class="h__ui">Law Information</h2>
            <section>
              <h3 class="h__ui--small">Cites</h3>
              <ul>
                <li>D.C. Law 22-207 (<a class="internal-link" href="http://lims.dccouncil.us/Download/37697/B22-0196-SignedAct.pdf">PDF</a>)</li>
                <li>D.C. Act 22-506 (<a class="internal-link" href="http://lims.dccouncil.us/Download/37697/B22-0196-SignedAct.pdf">PDF</a>)</li>
                <li>65 DCR 12365</li>
              </ul>
            </section>
            <section>
              <h3 class="h__ui--small">Effective</h3>
              <p>Feb. 22, 2019</p>
              <h3 class="h__ui--small">Legislative History (<a href="http://lims.dccouncil.us/Legislation/B22-0196">LIMS</a>)</h3>
              <p>Law 22-207, the “Access to Treatment for Anaphylaxis Act of 2018,” was introduced in the Council and assigned Bill No. 22-196 which was referred to the Committee on Health and Committee on Judiciary and Public Safety. The bill was adopted on first and second readings on Oct. 2, 2018, and Oct. 16, 2018, respectively. After mayoral review, it was assigned Act No. 22-506 on Oct. 31, 2018, and transmitted to Congress for its review. D.C. Law 22-207 became effective Feb. 22, 2019.</p>
            </section>
          </section>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__us-dc">
        <div id="section__footer__inner" class="ns__document__us-dc">
          <section id="area__footer__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal.png" srcset="/us/dc/_document/v2/images/logo/dc-seal.png 1x, /us/dc/_document/v2/images/logo/dc-seal@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </section>
          <div id="area__footer__content" class="ns__document__us-dc">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/law-html">HTML</a> or <a href="https://github.com/dccouncil/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
